MYRIAD GENETICS INC — Director's Dealing 2021

Sep 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2021-09-23

Reporting Person: DIAZ PAUL J (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-23	Common Stock	A	445439	$0.00	Acquired	845488	Direct
2021-09-23	Common Stock	F	49390	$34.76	Disposed	796098	Direct

Footnotes

F1: Consists of performance-based restricted stock units (PSUs) initially granted on October 8, 2020, subject to accomplishment of pre-determined performance metrics. On September 23, 2021, the Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on September 23, 2021, and the remaining seventy-five percent (75%) of the earned PSUs will vest in three (3) installments of 25% each on the following dates: August 13, 2022, August 13, 2023, and August 13, 2024.

F2: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 23, 2021.